A new metabotropic glutamate receptor agonist with in vivo anti-allodynic activity
Document Type
Article
Publication Date
1-1-2010
Abstract
As part of the vital search towards improved therapeutic agents for the treatment of neuropathic pain, the central nervous system glutamate receptors have become a major focus of research. Outlined herein are the syntheses of two new biologically active 3'-cycloalkyl-substituted carboxycyclopropylglycines, utilizing novel synthetic chemistry. The reaction between substituted 1,2-dioxines and an aminophosphonate furnished the cyclopropane core in a single step with all required stereochemistry of pendant groups. In vitro binding assays at metabotropic glutamate receptors revealed selective activity. In vivo testing in a rodent model of neuropathic pain indicated one amino acid significantly and dose-dependently decreased mechanical allodynia. (C) 2010 Elsevier Ltd. All rights reserved.
Keywords
1, 2-Dioxines, Carboxycyclopropylglycines, Metabotropic glutamate receptors, In vivo, Neuropathic pain, Allodynia
Publication Title
Bioorganic & Medicinal Chemistry
Recommended Citation
Stanley, N.J.; Hutchinson, M.R.; Kvist, T.; Nielsen, B.; Mathiesen, J.M.; Brauner-Osborne, H.; Avery, T.D.; Tiekink, E.R.T.; Pedersen, D.S.; Irvine, R.; Abell, A.D.; and Taylor, D.K., "A new metabotropic glutamate receptor agonist with in vivo anti-allodynic activity" (2010). Research Publications (2006 to 2010). 3007.
https://knova.um.edu.my/research_publications_2006_2010/3007
Volume
18
Issue
16
Publisher
Elsevier
Publisher Location
THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND